Skip to main content
Boryung Corporation logo

Boryung Corporation — Investor Relations & Filings

Ticker · 003850 ISIN · KR7003850005 KO Manufacturing
Open in API
Filings indexed 354 across all filing types
Latest filing 2018-12-12 Capital/Financing Update
Country KR South Korea
Listing KO 003850

About Boryung Corporation

https://pharm.boryung.co.kr/eng/index.do

Boryung Corporation is a fully integrated healthcare company founded in 1957. Its core business encompasses the research, development, manufacturing, and global commercialization of pharmaceutical products, with a significant presence in the cardiovascular therapeutic area. The company is distinguished by its pioneering 'Care in Space' (CIS) initiative, which focuses on developing healthcare solutions for humans in extreme environments and leveraging space for new research opportunities. In addition to its pharmaceutical operations, Boryung functions as a healthcare investment company, fostering innovation across the health sector. The company's diverse portfolio includes prescription drugs, over-the-counter products, and a pipeline aimed at addressing future medical needs.

Recent filings

Filing Released Lang Actions
유형자산취득결정
Capital/Financing Update Classification · 95% confidence The document is a regulatory announcement regarding the acquisition of tangible assets (land and buildings) by Boryung Pharmaceutical. It details the acquisition price, purpose, and board approval date. Since it is a specific corporate event announcement that does not fit into financial reporting, dividends, or management changes, it falls under the general regulatory filing category.
2018-12-12 Korean
최대주주변경
Board/Management Information Classification · 95% confidence The document is a regulatory filing regarding a change in the company's largest shareholder (maximum shareholder). It details the before and after ownership percentages and share counts, citing a merger as the reason for the change. This type of disclosure regarding significant shareholding changes and corporate structure adjustments falls under the 'Major Shareholding Notification' category.
2018-12-05 Korean
최대주주등소유주식변동신고서(최대주주변경시)
Major Shareholding Notification Classification · 100% confidence The document is a formal 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) filed by Boryung Pharmaceutical. It details the change in the largest shareholder and the ownership structure of related parties. This type of filing is a regulatory requirement for disclosing significant changes in ownership and control, which falls under the 'Major Shareholding Notification' category.
2018-12-05 Korean
연결재무제표기준영업실적등에대한전망(공정공시)
Earnings Release Classification · 95% confidence The document is a 'Fair Disclosure' (공정공시) filing from Boryung Pharmaceutical regarding their financial outlook (revenue and operating profit projections for 2018 and 2019). It provides forward-looking financial guidance and details regarding an investor presentation. Since it is a regulatory disclosure of financial projections rather than a full quarterly report or a simple announcement of a report's availability, it falls under the category of Regulatory Filings (RNS) as a general corporate disclosure. FY 2018
2018-12-05 Korean
대표이사(대표집행임원)변경(안내공시)
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the company's CEO (Representative Director). It lists the names of the outgoing and incoming directors, the reason for the change (resignation and new appointment), and the effective date. This falls directly under the definition of Board/Management Information (MANG).
2018-12-03 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement Classification · 95% confidence The document is a short announcement (639 characters) regarding the scheduling of an upcoming Investor Relations (IR) meeting. It provides the date, time, location, and purpose of the meeting, and explicitly states that the actual presentation materials will be made available on the company website on the day of the event. Per the 'Menu vs Meal' rule, this is an announcement of an event/report rather than the presentation itself, and it fits the definition of a Report Publication Announcement (RPA) or general regulatory filing regarding corporate events.
2018-12-03 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.